cytarabine has been researched along with Pink Eye in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (45.45) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aliff, TB; Frankel, SR; Jurcic, JG; Kalaycio, ME; Maslak, PG; Roma, TE; Scheinberg, DA; Tallman, MS; Weiss, MA | 1 |
| Carlo-Stella, C; Di Nicola, M; Gianni, AM; Guidetti, A; Magni, M; Marchesi, M; Matteucci, P | 1 |
| Spaeth, GL | 1 |
| Herzig, GP; Herzig, RH; Karanes, C; Lazarus, HM; Phillips, GL; Wolff, SN | 1 |
| Estey, E; Gandhi, V; Kantarjian, H; Keating, MJ; Plunkett, W; Rios, MB | 1 |
| Carrara, P; Cenacchi, A; Clavio, M; Gobbi, M; Manfroi, S; Ottaviani, E; Tosi, P; Tura, S; Visani, G; Zinzani, PL | 1 |
| Ahmed, T; Baskind, P; Darzynkiewicz, Z; Feldman, EJ; Goff, H; Pozzuoli, M; Santos, S; Seiter, K; Traganos, F | 1 |
| Gockerman, JP; Higa, GM; Horne, BJ; Hunt, AL; Jones, MR | 1 |
| Carter, RT; Cersosimo, RJ; Coderre, M; Karp, DD; Matthews, SJ | 1 |
| Fehr, J; Gmür, J; Hofmann, V; Honegger, HP; Morant, R; Sauter, C | 1 |
| Juel-Jensen, BE | 1 |
6 trial(s) available for cytarabine and Pink Eye
| Article | Year |
|---|---|
A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cognition; Conjunctivitis; Cytarabine; Dose-Response Relationship, Drug; Female; Fever; Heart; Hematemesis; Humans; Idarubicin; Male; Middle Aged; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Analysis; Treatment Outcome | 2002 |
Topical prophylaxis of conjunctivitis induced by high-dose cytosine arabinoside.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Conjunctivitis; Cytarabine; Dexamethasone; Diclofenac; Female; Humans; Male; Middle Aged; Premedication | 2006 |
Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplantation; Colitis; Combined Modality Therapy; Conjunctivitis; Cytarabine; Drug Administration Schedule; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Pancreatitis; Peripheral Nervous System Diseases; Remission Induction; Salvage Therapy; Treatment Outcome; Vidarabine | 1993 |
FLAG (fludarabine, cytarabine, G-CSF) as a second line therapy for acute lymphoblastic leukemia with myeloid antigen expression: in vitro and in vivo effects.
Topics: Adult; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Conjunctivitis; Cytarabine; Disease-Free Survival; Female; Glucocorticoids; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Ophthalmic Solutions; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Vidarabine | 1996 |
Phase II evaluation of a high-dose mitoxantrone based induction regimen in untreated adults with acute myeloid leukemia.
Topics: Actuarial Analysis; Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Conjunctivitis; Cytarabine; Disease-Free Survival; Etoposide; Female; Gastrointestinal Diseases; Humans; Hyperbilirubinemia; Leukemia, Myeloid; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Remission Induction; Risk; Stomatitis; Stroke Volume; Survival Analysis; Survival Rate; Treatment Outcome; Tretinoin; Ventricular Dysfunction, Left | 2000 |
The use of prophylactic eye drops during high-dose cytosine arabinoside therapy.
Topics: Adult; Aged; Conjunctivitis; Cytarabine; Dexamethasone; Double-Blind Method; Female; Humans; Keratitis; Leukemia, Myeloid, Acute; Male; Middle Aged; Ophthalmic Solutions; Prednisolone | 1991 |
5 other study(ies) available for cytarabine and Pink Eye
| Article | Year |
|---|---|
Chronic membranous conjunctivitis. A persisting problem.
Topics: Adrenal Cortex Hormones; Child; Chronic Disease; Conjunctivitis; Cytarabine; Drug Synergism; Humans; Idoxuridine; Male | 1967 |
High-dose cytosine arabinoside therapy for refractory leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Bone Marrow Diseases; Cerebellar Ataxia; Cognition Disorders; Conjunctivitis; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Eruptions; Hemorrhage; Humans; Leukemia; Middle Aged | 1983 |
Acute cerebellar syndrome, conjunctivitis, and hearing loss associated with low-dose cytarabine administration.
Topics: Aged; Cerebellar Diseases; Conjunctivitis; Cytarabine; Hearing Disorders; Humans; Male; Primary Myelofibrosis | 1987 |
[Effectiveness and toxicity of high-dosage Ara-C. Clinical observations in 10 cases and review of the literature].
Topics: Adolescent; Adult; Aged; Alopecia; Bone Marrow Diseases; Brain Diseases; Conjunctivitis; Cytarabine; Digestive System Diseases; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged | 1986 |
Herpes simplex and zoster.
Topics: Age Factors; Central Nervous System Diseases; Conjunctivitis; Cytarabine; Dimethyl Sulfoxide; Eczema; Female; Fingers; Genital Diseases, Female; Genital Diseases, Male; Herpes Simplex; Herpes Zoster; Humans; Idoxuridine; Immunologic Deficiency Syndromes; Infant, Newborn; Infant, Newborn, Diseases; Keratitis, Dendritic; Male; Simplexvirus; Steroids; Stomatitis | 1973 |